Due to the COVID-19 pandemic, this program will be held virtually using Zoom. Once registration is confirmed, you will receive an email invite with the Zoom link two days before the start of the program.
Diana Kolman, MD
Director of Interventional Pulmonology
Capital Health - Pulmonology Specialists
Africa Wallace, MD
Director, Thoracic Surgery
Capital Health Surgical Group
Khanh Nguyen, MD, MA
Capital Health Cancer Center
Scott Kindsfather, MD
Mercer Bucks Hematology Oncology, P.C.
Primary Care, Internal Medicine, Pulmonary, Medical & Radiation Oncologists, APN, PA and Medical Residents
Upon completion of the program, participants will be able to:
- Review the Interventional options for non-operative early/late stage lung cancer.
- Discuss the cutting-edge surgical options for lung cancer.
- Summarize the role/indications for SBRT (CyberKnife®) treatment for early stage lung cancers.
- Utilize targeted and immunotherapy options for lung cancer.
Capital Health is accredited by the Medical Society of New Jersey to provide continuing medical education to physicians. Capital Health designates this for a maximum of 2 AMA PRA CategoryTM Physicians should only claim credit commensurate with the extent of their participation in the activity.